Mathai Mammen - 11 May 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Mathai Mammen
Issuer symbol
TXG
Transactions as of
11 May 2023
Net transactions value
-$1,511,086
Form type
4
Filing time
15 May 2023, 16:37:41 UTC
Previous filing
17 Jun 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $232,000 +200,000 +7286% $1.16* 202,745 11 May 2023 Direct
transaction TXG Class A Common Stock Sale $1,743,086 -33,000 -16% $52.82 169,745 11 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -200,000 -100% $0.000000* 0 11 May 2023 Class A Common Stock 200,000 $1.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $52.43 to $53.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F2 All of the shares subject to the option are fully vested and exercisable as of the date hereof.